StemSight
Pre-clinicalStemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
Founded
2018
Focus
Cell & Gene Therapy
About
StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
Company Info
TypePrivate
Founded2018
LocationHelsinki, Finland
StagePre-clinical
Contact
SIMILAR COMPANIES
3PBIOVIAN
Pre-clinical · Turku
Faron Pharmaceuticals
Phase 1/2 · Turku
Finvector Vision Therapies
Pre-clinical · Kuopio
Bone Index
Pre-clinical · Kuopio
Genomill Health
Pre-clinical · Helsinki
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile